Clinical Trials in Tennessee

Showing 7381-7400 of 15,329 trials

A Study of LY3023414 in Participants With Advanced Cancer

NCT01655225

The purpose of this study is to find a recommended dose level and schedule of dosing LY3023414 that can safely be taken by participants with advanced or metastatic cancer. The study will also explore the changes to various markers in blood cells and potentially tumor cells. Finally, the study will help document any antitumor activity this drug may have. In Part A of this study, participants with advanced/metastatic cancer (including lymphoma) will receive increasing doses of LY3023414. In Part B, LY3023414 will be explored in different types of cancer, including breast and lung cancer, lymphoma and mesothelioma.

Advanced CancerMetastatic CancerNon-Hodgkin's Lymphoma+3 more

Eli Lilly and Company156 participantsStarted Jul 2012

Los Angeles, California, United States • New York, New York, United States • Oklahoma City, Oklahoma, United States +5 more locations

COMPLETEDPhase 329 miles

Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok

NCT00539981

The purpose of this study was to evaluate a single dose of FluBlok in terms of safety, efficacy and effectiveness in prevention of influenza and influenza-like illness and assess clinical lot-to-lot consistency in manufacturing by evaluating and comparing the immunogenicity of three different lots of FluBlok in a subset of participants.

Influenza

Sanofi4,648 participantsStarted Sep 2007

Beverly Hills, California, United States • Sacramento, California, United States • San Francisco, California, United States +21 more locations

A Study of LY3023414 in Participants With Advanced Cancer

Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok

Find Trials by Condition in Tennessee

A Study to Assess the Efficacy and Safety of XP23829 in Subjects With Moderate-to-Severe Chronic Plaque-Type Psoriasis

Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer

Supported Employment Demonstration

PMCF Study on PEEK Suture Anchors for Shoulder Indications

INtervention Study In overweiGHT Patients With COPD

A Study to Assess Efficacy and Safety of HL036 in Subjects With Dry Eyes

Study of Denileukin Diftitox in Participants With Stage IIIC and Stage IV Melanoma

Olaparib Tablets as a Treatment for Ovarian Cancer Subjects With Different HRD Tumor Status

Illness Management and Parental Adjustment to Cancer Treatment

InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I )

Benign Liver Optimal Core Study (Tissue Acquisition Comparison in Benign Liver Disease)

Plasma Adsorption in Patients With Confirmed COVID-19

A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors

Screening for Colonization With Resistant Enterobacterales in Neutropenic Patients With Hematologic Malignancies

OCS Lung Expand Post-Approval Study - Expand Follow-Up Data Collection

COVID-19 Vaccines Safety Tracking (CoVaST)

Early Feasibility Study of UV-Femtosecond Laser Assisted Lenticular Extraction

Immunogenicity and Safety of a Meningococcal Conjugate Vaccine Given Concomitantly With Other Vaccines in Toddlers